Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Estimated Prevalence and Testing for Albuminuria in US Adults at Risk for Chronic Kidney Disease
Chi D. Chu, Fang Xia, Yuxian Du, et al.
JAMA Network Open (2023) Vol. 6, Iss. 7, pp. e2326230-e2326230
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD
Sankar D. Navaneethan, Nisha Bansal, Kerri L. Cavanaugh, et al.
American Journal of Kidney Diseases (2024)
Closed Access | Times Cited: 17
Albuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review
Sophie E. Claudel, Ashish Verma
Circulation (2025) Vol. 151, Iss. 10, pp. 716-732
Closed Access | Times Cited: 3
Positive association between blood ethylene oxide levels and metabolic syndrome: NHANES 2013-2020
Chunqi Zhou, Senlin Wang, Lingling Ju, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 11
Association of oxidative balance score with chronic kidney disease: NHANES 1999-2018
Haibin Wen, Xianhua Li, Jiangming Chen, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 11
Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan
Navdeep Tangri, Anjay Rastogi, Cassandra Nan, et al.
Advances in Therapy (2024) Vol. 41, Iss. 3, pp. 1151-1167
Open Access | Times Cited: 9
Association of prebiotic/probiotic intake with MASLD: evidence from NHANES and randomized controlled trials in the context of prediction, prevention, and a personalized medicine framework
Senlin Wang, Ruimin Zhang, Peisen Guo, et al.
The EPMA Journal (2025)
Closed Access | Times Cited: 1
Risk-directed management of chronic kidney disease
Matthew F. Blum, Brendon L. Neuen, Morgan E. Grams
Nature Reviews Nephrology (2025)
Closed Access | Times Cited: 1
Cardiovascular-Kidney-Metabolic Health Syndrome
Nisha Bansal, Daniel E. Weiner, Mark J. Sarnak
Journal of the American Society of Nephrology (2024) Vol. 35, Iss. 5, pp. 649-652
Open Access | Times Cited: 8
Concordance With Screening and Treatment Guidelines for Chronic Kidney Disease in Type 2 Diabetes
Daniel Edmonston, Elizabeth Lydon, Hillary Mulder, et al.
JAMA Network Open (2024) Vol. 7, Iss. 6, pp. e2418808-e2418808
Open Access | Times Cited: 7
Screening for chronic kidney disease: change of perspective and novel developments
Dominique van Mil, Lyanne M. Kieneker, Hiddo J.L. Heerspink, et al.
Current Opinion in Nephrology & Hypertension (2024) Vol. 33, Iss. 6, pp. 583-592
Open Access | Times Cited: 5
Estimating the population-level impacts of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease: a cross-sectional observational study using routinely collected Australian primary care data
Brendon L. Neuen, Min Jun, James Wick, et al.
The Lancet Regional Health - Western Pacific (2023) Vol. 43, pp. 100988-100988
Open Access | Times Cited: 13
Does amino acid infusion reduce the risk of clinically significant acute kidney injury following cardiac surgery?
Suneel Ramesh Desai, Nian Chih Hwang
Journal of Cardiothoracic and Vascular Anesthesia (2025)
Closed Access
Transforming Traditional Industry Advisory Boards Into Mutually Beneficial Strategic Think Tanks: A Peer Review Council Case Series and Best Practices
Todd Williamson, John Fox, Scott Ramsey, et al.
Journal of Pharmaceutical Innovation (2025) Vol. 20, Iss. 1
Open Access
High prevalence of unrecognized chronic kidney disease in the Lolland-Falster Health Study: a population-based study in a rural provincial area of Denmark
Ebba Mannheimer, Morten Buus Jørgensen, Kristine Hommel, et al.
European Journal of Public Health (2025)
Open Access
Treating chronic kidney disease in Danish primary care: results from the observational ATLAS study
Morten Lindhardt, Søren Tang Knudsen, Thomas Saxild, et al.
BMC Primary Care (2025) Vol. 26, Iss. 1
Open Access
Association of Podometrics Findings in Patients With Hypertension and Type 2 Diabetes: A Retrospective Analysis
Christopher Paschen, Maximilian C. Koeller, Helga Schachner, et al.
Hypertension (2025)
Closed Access
Population Health Management for Improving Kidney Health Outcomes
Manisha Jhamb, Jane O. Schell, Melanie R. Weltman, et al.
American Journal of Kidney Diseases (2025)
Open Access
Global, regional and country‐specific burden of chronic kidney disease due to type 1 diabetes mellitus: A systematic analysis of the 2021 global disease burden study
Jianran Sun, Wan Hu, Shandong Ye, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
Developments in albuminuria testing: A key biomarker for detection, prognosis and surveillance of kidney and cardiovascular disease—A practical update for clinicians
Jelle M. Beernink, Dominique van Mil, Gozewijn D. Laverman, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
Prediction of Future Risk of Moderate to Severe Kidney Function Loss Using a Deep Learning Model–Enabled Chest Radiography
Kai-Chieh Chen, S. S. Lee, Dung-Jang Tsai, et al.
Deleted Journal (2025)
Closed Access
Using guideline-directed medical therapies to improve kidney and cardiovascular outcomes in patients with chronic kidney disease
Thelma Barber, Joshua J. Neumiller, Michelle A. Fravel, et al.
American Journal of Health-System Pharmacy (2025)
Closed Access
Effectiveness of a systematic home-based albuminuria screening programme to detect chronic kidney disease in high-risk individuals in primary care (SALINE): a cross-sectional screening study
Dominique van Mil, Lyanne M. Kieneker, Evelien Harms, et al.
EClinicalMedicine (2025) Vol. 82, pp. 103185-103185
Open Access
The interplay between heart failure and chronic kidney disease
Anuradha Lala, Adeera Levin, Kamlesh Khunti
Diabetes Obesity and Metabolism (2025)
Open Access
Albuminuria, Forgotten No More: Underlining the Emerging Role in CardioRenal Crosstalk
Gregorio Romero‐González, Néstor Rodríguez, Carles Cañameras, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 3, pp. 777-777
Open Access | Times Cited: 3
Challenges and Strategies in Implementing Novel Kidney Protective and Cardioprotective Therapies in Patients With Diabetes and Kidney Disease
Christine P. Limonte, Julio A. Lamprea‐Montealegre, Katherine R. Tuttle
Seminars in Nephrology (2024) Vol. 44, Iss. 2, pp. 151520-151520
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top